Lantheus Holdings, Inc. Current Liabilities
Lantheus Holdings, Inc. (LNTH) had Current Liabilities of $335.68 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $335.68M.
- 2026-03-31: Liabilities, Current $333.17M.
- 2025-12-31: Liabilities, Current $333.42M.
- 2025-09-30: Liabilities, Current $346.84M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $335.68M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $333.17M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $333.42M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $346.84M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $280.13M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $248.00M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $240.53M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $784.08M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $263.29M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $237.20M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $187.35M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $176.60M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $154.04M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $276.39M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $247.70M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $235.98M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $219.02M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $177.66M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $90.50M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $76.90M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $73.83M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $64.59M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $80.50M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $82.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $76.34M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $61.96M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $66.11M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $59.59M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $53.36M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $42.77M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $52.76M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $54.58M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $43.25M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $45.40M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $46.75M 10-K · filed 2019-02-20 | |
| 2017-09-30 | $46.09M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $43.06M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $39.13M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $43.84M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $39.12M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $34.09M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $31.48M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $35.52M 10-K · filed 2017-02-23 | $35.72M 10-K · filed 2016-03-02 |
| 2015-09-30 | $34.32M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $37.55M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $48.53M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |